Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$62.12 - $84.15 $24,226 - $32,818
-390 Reduced 86.67%
60 $4,000
Q1 2024

May 07, 2024

SELL
$65.98 - $77.09 $124,438 - $145,391
-1,886 Reduced 80.74%
450 $31,000
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $167,304 - $202,344
2,336 New
2,336 $173,000
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $54,530 - $75,627
-193 Reduced 31.9%
412 $117,000
Q2 2022

Aug 08, 2022

SELL
$322.67 - $449.65 $133,908 - $186,604
-415 Reduced 40.69%
605 $209,000
Q1 2022

May 10, 2022

BUY
$353.85 - $487.79 $212,663 - $293,161
601 Added 143.44%
1,020 $441,000
Q4 2021

Feb 11, 2022

SELL
$456.15 - $525.06 $350,779 - $403,771
-769 Reduced 64.73%
419 $217,000
Q3 2021

Nov 08, 2021

BUY
$444.87 - $538.88 $8,007 - $9,699
18 Added 1.54%
1,188 $575,000
Q2 2021

Aug 09, 2021

SELL
$387.35 - $450.26 $42,995 - $49,978
-111 Reduced 8.67%
1,170 $527,000
Q1 2021

Apr 28, 2021

BUY
$314.62 - $411.0 $391,072 - $510,873
1,243 Added 3271.05%
1,281 $489,000
Q4 2020

Feb 09, 2021

SELL
$246.9 - $321.87 $220,234 - $287,108
-892 Reduced 95.91%
38 $12,000
Q3 2020

Nov 02, 2020

BUY
$232.22 - $282.96 $76,864 - $93,659
331 Added 55.26%
930 $230,000
Q2 2020

Aug 11, 2020

BUY
$185.43 - $279.56 $60,450 - $91,136
326 Added 119.41%
599 $158,000
Q1 2020

May 15, 2020

BUY
$161.17 - $221.51 $1,611 - $2,215
10 Added 3.8%
273 $52,000
Q4 2019

Feb 13, 2020

SELL
$189.68 - $222.09 $948 - $1,110
-5 Reduced 1.87%
263 $57,000
Q3 2019

Oct 17, 2019

SELL
$183.56 - $216.72 $167,590 - $197,865
-913 Reduced 77.31%
268 $52,000
Q4 2018

Jan 17, 2019

BUY
$132.75 - $203.8 $62,392 - $95,786
470 Added 66.1%
1,181 $170,000
Q3 2018

Nov 02, 2018

BUY
$147.44 - $204.11 $72,098 - $99,809
489 Added 220.27%
711 $0
Q2 2018

Jul 24, 2018

BUY
$144.9 - $165.58 $32,167 - $36,758
222 New
222 $0

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.